Dr. Daniel Solomon, MD

• Infectious Disease Medicine

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Yale University

  Medical School, 2010

• Measuring Concurrent Adherence to Multiple Related Medications, 2010-05-10

• Low-Dose Methotrexate for the Prevention of Atherosclerotic Events, 2018-11-10

• Matching weights to simultaneously compare three treatment groups: Comparison to three-way matching, 2017-01-31

• New loop diuretic prescriptions may be an acute risk factor for falls in the nursing home, 2012-03-16

• ChatGPT , et al … Artificial Intelligence, Authorship, and Medical Publishing SOLOMON ET AL, 2023-04-10

• Placing a Price on Medical Device Innovation: The Example of Total Knee Arthroplasty, 2013-05-06

• The implications of theSequestosome 1mutation P392L in patients with Paget's disease in a United States cohort, 2015-12-28

• Physical and Behavioral Factors Associated With Improvement in Physical Health and Function Among US Women During Midlife Factors Associated With Improvement in Women's Physical Health During Midlife, 2023-05-01

• The Potential Economic Benefits of Improved Postfracture Care: A Cost-Effectiveness Analysis of a Fracture Liaison Service in the US Health-Care System, 2014-09-16

• Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement, 2017-06-13

• CORRELATIONS OF NURSING HOME CHARACTERISTICS WITH PRESCRIPTION OF OSTEOPOROSIS MEDICATIONS, 2011-02-21

• The MeTeOR Trial (Meniscal Tear in Osteoarthritis Research): Rationale and Design Features, 2012-09-05

• An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score, 2015-04-13

• Risk of Incident Atrial Fibrillation in Gout: a Cohort Study, 2015-08-31

• The Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis, 2014-06-04

• Adipokine Hormones and Hand Osteoarthritis: Radiographic Severity and Pain, 2012-10-26

• Effects of Disease-Modifying Antirheumatic Drugs on Non-Vertebral Fracture Risk in Rheumatoid Arthritis: a Population-based Cohort Study, 2013-07-03

• Prevalence and predictors for sustained remission in rheumatoid arthritis, 2019-04-19

• Correction to: Association between inflammation and systolic blood pressure in RA compared to patients without RA, 2019-07-08

• Confounder Summary Scores When Comparing the Effects of Multiple Drug Exposures, 2009-09-15

• An Evaluation of the Relationship Between the Implementation of a Newly Designed Prescription Drug Label at Target Pharmacies and Health Outcomes, 2010-05-10

• Effects of Analgesics on Bone Mineral Density: a Longitudinal Analysis of the Prospective SWAN Cohort with Three-group Matching Weights, 2017-12-12

• Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Women with Systemic Lupus Erythematosus Receiving Immunosuppressive Drugs, 2016-10-31

• Anti-histamine Therapy and Bone Mineral Density: Analysis in a Population-Based U.S. Sample, 2010-08-03

• Risk of incident diabetes in patients with gout: a cohort study, 2015-03-26

• End-Stage Renal Disease due to Lupus Nephritis among Children in the U.S., 1995-2006, 2011-03-22

• Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis, 2010-08-03

• Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States, 2012-07-05

• Sociodemographic, Disease, Health System, and Contextual Factors Affecting the Initiation of Biologic Agents in Rheumatoid Arthritis: A Longitudinal Study, 2014-07-08

• Decreasing medical complications for total knee arthroplasty: Effect of Critical Pathways on Outcomes, 2010-07-14

• Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries, 2017-04-17

• Pseudogout among Patients Fulfilling a Billing Code Algorithm for Calcium Pyrophosphate Deposition Disease, 2018-04-17

• Gout and the Risk of Non-vertebral Fracture, 2016-09-06

• Treatment of rheumatoid arthritis in the Medicare Current Beneficiary Survey, 2013-03-18

• Physician Prescribing Patterns and Risk for Future Chronic Opioid Use among Patients with Rheumatoid Arthritis: A Prospective Observational Cohort Study, 2020-03-19

• Assessing the Need for Improved Access to Rheumatology Care: A Survey of Massachusetts Community Health Center Medical Directors, 2013-10-17

• Initiation of Tumor Necrosis Factor Alpha (TNFa) antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases, 2012-12-31

• Validation of rheumatoid arthritis diagnoses in health care utilization data, 2011-02-23

• Association between inflammation and systolic blood pressure in RA compared to patients without RA, 2018-06-01

• Changes in Use of Disease Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in the U.S. for the period 1983-2009, 2013-03-18

• Medication Nonadherence is Associated with Increased Subsequent Acute Care Utilization among Medicaid Beneficiaries with Systemic Lupus Erythematosus, 2015-06-26

• Sustained rheumatoid arthritis remission is uncommon in clinical practice, 2012-03-19

• Identification of smoking using Medicare data- A validation study of claims-based algorithms, 2016-01-13

• Epidemiology and Sociodemographics of Systemic Lupus Erythematosus and Lupus Nephritis among U.S. Adults with Medicaid Coverage, 2000-2004, 2013-07-11

• Rheumatoid Arthritis and Cardiovascular Disease, 2013-08-29

• Improving the Pharmacologic Management of Pain in Older Adults: Identifying the Research Gaps and Methods to Address Them, 2011-08-11

• Resource Utilization in Cancer Patients with Bisphosphonate-Associated Osteonecrosis of the Jaw, 2013-02-19

• Improving rheumatoid arthritis comparative effectiveness research through causal inference principles: systematic review using a target trial emulation framework, 2020-05-07

• Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal Disease, 2013-12-26

• Changes in co-therapies after initiation of disease-modifying anti-rheumatic drugs (DMARDs) therapy in patients with rheumatoid arthritis, 2011-08-13

• Immediate Open Access: The Good, the Bad, and the Impact on Academic Society Publishing SAWALHA ET AL, 2023-05-12

• Malignancy validation in a United States registry of rheumatoid arthritis patients, 2012-05-31

• Tumor necrosis factor-a inhibitor use and the risk of incident hypertension in patients with rheumatoid arthritis, 2017-04-29

• The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy, 2021-01-14

• Pain Severity in Relation to the Final Menstrual Period in a Prospective Multiethnic Observational Cohort: Results from the Study of Women's Health Across the Nation (SWAN), 2016-11-09

• Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis Initiating Disease-Modifying Antirheumatic Drugs, 2014-12-20

• The Association between Statin use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults, 2011-04-22

• An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout, 2018-02-28

• Comparative safety and effectiveness of denosumab versus zoledronic acid in patients with osteoporosis: A cohort study, 2017-02-07

• Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors among Medicaid Beneficiaries with Systemic Lupus Erythematosus, 2018-10-23

• The number of persons with symptomatic knee osteoarthritis in the United States: Impact of race/ethnicity, age, sex, and obesity, 2016-11-03

• Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practice, 2019-01-24

• Statin Therapy and Risk of Fracture: Results from the JUPITER Randomized Clinical Trial, 2015-09-17

• Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments, 2012-11-26

• Patterns of prescription opioid use before total hip and knee replacement among US Medicare enrollees, 2019-06-26

• Acute Calcium Pyrophosphate Crystal Arthritis Flare Rate and Risk Factors for Recurrence, 2019-11-01

• Tumor Necrosis Factor Alpha Inhibitor Therapy and Cancer Risk In Chronic Immune Mediated Diseases, 2013-07-25

• Unresolved Questions in Rheumatology: Motion for Debate: The Data Support Evidence-Based Management Recommendations for Cardiovascular Disease in Rheumatoid Arthritis, 2013-07-02

• Comparison of a new three-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease, 2020-06-24

• Initiation of tumor necrosis factor-a antagonists and the risk of hospitalization for infection in patients with autoimmune diseases, 2011-11-06

• Study Design for a Comprehensive Assessment of Biologic Safety Using Multiple Healthcare Data Systems, 2011-09-15

• Impact of changes in inflammation on estimated 10-year cardiovascular risk in rheumatoid arthritis, 2018-08-01

• TNFa Inhibitors May Improve Asthma Symptoms: A Case Series of 12 Patients with Rheumatoid Arthritis and Asthma, 2010-09-17

• Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis, 2015-04-17

• Association of geography and access to healthcare providers with long term prescription opioid use in Medicare patients with severe osteoarthritis: A cohort study, 2019-04-02

• Rationale and design of the S tudy of a T ele-pharmacy I ntervention for C hronic diseases to I mprove T reatment adherence (STIC2IT): A cluster randomized pragmatic trial, 2016-08-08

• Use of Disease-Modifying Antirheumatic Drugs During Pregnancy and Risk of Preeclampsia, 2012-08-29

• HIV and its effects on bone: A primer for rheumatologists, 2015-12-11

• The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28, 2006-03-14

• The performance of matrix-based risk models for rapid radiographic progression in BRASS, a cohort of patients with established rheumatoid arthritis, 2012-10-13

• Comparative Rates of Serious Infections among Patients with Systemic Lupus Erythematosus Receiving Immunosuppressive Medications, 2016-08-25

• Subgroup Analyses to Determine Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs and Coxibs in Specific Patient Groups, 2008-08-15

• A comparison of statistical approaches for physician-randomized trials with survival outcomes, 2011-09-06

• Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study, 2008-08-21

• The Prevalence and Cost of Unapproved Uses of Top-Selling Orphan Drugs, 2012-02-21

• Comparative safety of non-steroidal anti-inflammatory drugs, 2013-07-05

• Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study, 2011-06-08

• Comparative Safety of Antidepressant Agents for Children and Adolescents Regarding Suicidal Acts, 2010-04-12

• Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis, 2019-01-23

• Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-grade Cervical Dysplasia and Cervical Cancer in Rheumatoid Arthritis: a Cohort Study, 2016-04-08

• Interstate Variation in the Burden of Fragility Fractures, 2008-12-08

• The Risk of Atrial Fibrillation in Patients with Rheumatoid Arthritis, 2013-04-20

• Bisphosphonates and risk of atrial fibrillation: a meta-analysis, 2010-02-19

• A SAS Macro for a Clustered Permutation Test, 2009-03-24

• Incidence and Predictors of Secondary Fibromyalgia in an Early Arthritis Cohort, 2012-07-11

• Bisphosphonates and Risk of Subtrochanteric, Femoral Shaft, and Atypical Femur Fracture: A Systematic Review and Meta-analysis, 2013-03-18

• Original Article: A Tool for Empirical Equipoise Assessment in Multi-group Comparative Effectiveness Research, 2019-05-27

• Rheumatoid arthritis quality measures and radiographic progression, 2014-01-25

• Identification and Validation of Vertebral Compression Fractures using Administrative Claims Data, 2009-05-18

• Strategies for Making Analgesia Safer: The Role of Comparative Effectiveness Research, 2014-05-24

• Race/Ethnicity and Cardiovascular Events among Patients with Systemic Lupus Erythematosus, 2017-08-13

• Alternative Methods for Defining Osteoarthritis and the Impact on Estimating Prevalence in a US Population-Based Survey, 2015-09-29

• Atrial Fibrillation/Flutter Hospitalizations among U.S. Medicaid Recipients with and without Systemic Lupus Erythematosus, 2019-11-01

• The relationship between hand osteoarthritis and serum leptin concentration in participants of the Third National Health and Nutrition Examination Survey, 2012-05-31

• The role of sleep problems in central pain processing in rheumatoid arthritis, 2012-10-09

• Do Rheumatologists Know Best? An Outcomes Study of Inconsistent Users of Disease-Modifying Anti-Rheumatic Drugs, 2014-08-27

• Comment on:Comorbidity burden in axial spondyloarthritis: Reply, 2020-03-01

• The association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-RA, 2015-04-25

• Association between the initiation of anti-TNF therapy and the risk of herpes zoster, 2013-03-06

• Association Between Anti-TNF-a Therapy and Interstitial Lung Disease, 2013-01-29

• Privacy-Maintaining Propensity Score-Based Pooling of Multiple Databases Applied to a Study of Biologics, 2010-08-03

• Challenges in Implementing Treat to Target Strategies in Rheumatology, 2021-09-30

• Impact of the US Food and Drug Administration's safety-related announcements on the use of bisphosphonates after hip fracture, 2016-03-31

• The Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients with Rheumatoid Arthritis, 2022-12-12

• Racial/Ethnic Variation in Stroke Rates and Risks among Patients with Systemic Lupus Erythematosus, 2018-07-31

• Disease modifying anti-rheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: A retrospective cohort study, 2016-02-01

• Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis, 2019-07-22

• Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry, 2016-12-01

• Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome, 2018-06-20

• Use of Data from Multiple Registries in Studying Biologic Discontinuation: Challenges and Opportunities, 2013-10-03

• Outcomes of a Mobile App to Monitor Patient Reported Outcomes in Rheumatoid Arthritis: A Randomized Controlled Trial, 2021-06-18

• Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals, 2012-06-07

• Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout, 2018-05-30

• Factors associated with fractures in HIV-infected persons: which factors matter?, 2016-07-15

• Assessment of coronary vascular function with cardiac PET in relation to serum uric acid, 2018-02-13

• Validation of Claims-Based Algorithms for Gout Flares, 2016-05-27

• Active-comparator design and new-user design in observational studies, 2015-03-24

• Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer, 2013-09-12

• Tumor necrosis factor blockade and the risk of viral infection, 2010-02-09

• Non-viral Opportunistic Infections in New Users of TNF Inhibitor Therapy: Results of the SAfety Assessment of Biologic ThERapy (SABER) Study, 2013-07-13

• The relationship between fish consumption and disease activity in rheumatoid arthritis, 2018-02-06

• Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study, 2014-03-11

• Subsequent Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment, 2018-05-30

• A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries, 2010-09-27

• Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study, 2015-02-03

• Risk of Hepatitis B Reactivation in Inflammatory Arthritis Patients Receiving Disease Modifying Anti-Rheumatic Drugs (DMARDs): a Systematic Review and Meta-analysis, 2018-04-12

• Classifying Pseudogout using Machine Learning Approaches with Electronic Health Record Data, 2020-01-08

• Validation of a bioassay for predicting response to TNFa inhibitors in rheumatoid arthritis, 2021-04-16

• Association of Preoperative Opioid Use With Mortality and Short-term Safety Outcomes After Total Knee Replacement Association of Preoperative Opioid Use With Mortality and Safety Outcomes After Total Knee Replacement, 2019-07-31

• Accuracy of identifying neutropenia diagnoses in outpatient claims data, 2011-05-12

• Area-level Predictors of Medication Nonadherence among U.S. Medicaid Beneficiaries with Lupus: A Multilevel Study, 2018-07-30

• Serious infection incidence rates in pediatric systemic lupus erythematosus according to medication use, 2014-09-18

• Sleep Medications and Sleep Disturbances Across Middle Aged Pre- or Peri-Menopausal Women of Different Race and Ethnicities: A SWAN Pharmacoepidemiology Cohort Study, 2020-08-18

• Association Between Anti-TNF-a Therapy and All-Cause Mortality, 2012-10-15

• Validity of Self-report of Infections in a Longitudinal Cohort of Patients with Rheumatoid Arthritis Differs by Source of Report and Infection Severity, 2010-04-28

• The impact of smoking on response to TNF inhibitors in axial spondyloarthritis: methodological considerations for longitudinal observational studies, 2019-02-14

• Gout and Risk of Fracture in Women: A Prospective Cohort Study, 2016-08-23

• TNF Antagonists: Killing Two "Birds” with one Biologic "Stone”, 2018-02-13

• TRAF1/C5but NotPTPRCVariants Are Potential Predictors of Rheumatoid Arthritis Response to Anti-Tumor Necrosis Factor Therapy, 2015-03-05

• Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study, 2014-06-11

• Patterns of disease-modifying anti-rheumatic drug use in rheumatoid arthritis patients after 2002: a systematic review, 2014-10-01

• Primary care physicians' perspectives towards managing rheumatoid arthritis: room for improvement, 2011-11-18

• Inconsistent treatment with disease-modifying anti-rheumatic drugs: a longitudinal data analysis, 2014-10-15

• Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin or pregabalin, 2014-06-04

• Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations, 2016-04-26

• Pulmonary adverse events of low-dose methotrexate in the randomized double-blind placebo-controlled Cardiovascular Inflammation Reduction Trial, 2020-10-07

• A Development and Feasibility Study of a Peer Support Telephone Program in Rheumatoid Arthritis, 2019-08-08

• Lifetime medical costs of knee osteoarthritis management in the United States: Impact of extending indications for total knee arthroplasty, 2015-04-30

• Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006, 2014-09-18

• Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort, 2011-07-22

• Clinical and health care use characteristics of patients newly prescribed allopurinol, febuxostat and colchicine for gout, 2014-06-04

• Biologic Discontinuations Studies: A Systematic Review of Methods, 2013-05-30

• Systematic Review and Meta-analysis of Methotrexate Use and Risk of Cardiovascular Disease, 2011-08-17

• Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings, 2018-07-19

• Opioid Analgesics and the Risk of Fractures Among Older Adults with Arthritis, 2012-05-16

• Factors Associated With 10-Year Declines in Physical Health and Function Among Women During Midlife Factors Associated With Declines in Physical Health and Function During Midlife, 2022-01-10

• DMARD non-use in low-income, elderly rheumatoid arthritis patients: results of 86 structured interviews, 2014-01-29

• Patterns of Systemic Treatment for Psoriatic Arthritis in the United States: 2004-2015, 2018-03-23

• Rheumatoid arthritis disease activity assessed by patient-reported outcomes and flow cytometry before and after an additional dose of COVID-19 vaccine, 2022-02-15

• Cardiovascular Risks in Older Patients with Gout Initiating Probenecid versus Allopurinol: a Cohort Study, 2018-03-06

• Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: a Population-based Cohort Study, 2018-09-11

• Oral Bisphosphonates and Risk of Subtrochanteric or Diaphyseal Femur Fractures in a Population-Based Cohort, 2010-11-18

• Linkage of a De-identified United States Rheumatoid Arthritis Registry with Administrative Data to Facilitate Comparative Effectiveness Research, 2014-10-10

• Is race or ethnicity associated with under-utilization of statins among women in the United States: The study of women's health across the nation, 2020-08-30

• The Relationship Between 19-Year Trends in Medication Use and Changes in Physical Function Among Women in the Mid-Life: A SWAN Pharmacoepidemiology Study, 2021-09-21

• Rationale and Design of the Cardiovascular Inflammation Reduction Trial (CIRT): A Test of the Inflammatory Hypothesis of Atherothrombosis, 2013-05-03

• A Blinded Randomized Controlled Trial of Motivational Interviewing to Improve Adherence with Osteoporosis Medications: Design of the OPTIMA Trial, 2009-05-13

• Arterial FDG Uptake in Rheumatoid Arthritis Correlates with Synovial Activity: A Human FDG-PET/CT Study, 2019-11-09

• Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR), 2017-08-16

• IgG galactosylation aberrancy precedes disease onset, correlates with disease activity and is prevalent in autoantibodies in rheumatoid arthritis, 2014-06-17

• Physician Preference Motivates Use of Anti-TNF Therapy Independent of Clinical Disease Activity, 2010-01-15

• Bone Mineral Density Changes Among Women Initiating Proton Pump Inhibitors or H2 Receptor Antagonists: A SWAN Cohort Study, 2015-04-15

• Lifetime risk and age of diagnosis of symptomatic knee osteoarthritis in the US, 2013-12-25

• The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study, 2009-10-29

• Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data, 2022-05-28

• Dynamic Patterns and Predictors of Hydroxychloroquine Nonadherence among Medicaid Beneficiaries with Systemic Lupus Erythematosus, 2018-01-08

• Cancer screening rates in patients with rheumatoid arthritis: no different than the general population, 2012-05-11

• The Relationship Between Focal Erosions and Generalized Osteoporosis in Postmenopausal Women with Rheumatoid Arthritis: The Osteoporosis in Rheumatoid Arthritis (OPiRA) Cohort Study, 2009-05-19

• Intensification to triple therapy non-biologic disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States from 2009 to 2014, 2016-10-12

• Placebo Adherence, Clinical Outcomes and Mortality in the Women's Health Initiative Randomized Hormone Therapy Trials, 2014-10-08

• The clinical status and economic savings associated with remission among patients with rheumatoid arthritis:Leveraging linked registry and claims data for synergistic insights, 2016-12-28

• Trends in the Incidence, Demographics and Outcomes of End-Stage Renal Disease Due to Lupus Nephritis in the U.S., 1995-2006, 2011-02-07

• Variation in Initial Kidney Replacement Therapy for End-Stage Renal Disease Due to Lupus Nephritis in the U.S., 2011-08-24

• Uptake of the First Biosimilar Infliximab since its Approval in South Korea, 2016-01-31

• Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study, 2017-02-10